In 2023, the Chinese IVD market reached a value of USD 16.6 billion, showing steady growth after adjusting for the impact of COVID-19. Imported products made up 50% of total sales, an increase from 40% in 2022. The demand for clinical immunology saw a strong annual growth of 15%, highlighting its expansion. Notably, 65% of immunology products were imported, underscoring significant opportunities for international players, particularly in the high-end market segment. Brought to you by the Canadian Trade Commissioner Service (TCS) in Shanghai with co-organizer China Association of In Vitro Diagnostics, this capacity-building webinar offers in-market expert insights as well as comprehensive coverage of business-essential preparatory topics, including market overview analysis, competitive landscape, commercial segmentation, regulatory pathways, product positioning, cross-border business partnership and key IP considerations.